Abbott Laboratories (LON: 0Q15)
London
· Delayed Price · Currency is GBP · Price in USD 127.89
-1.10 (-0.85%)
At close: Jan 31, 2025
Abbott Laboratories Revenue
In the year 2024, Abbott Laboratories had annual revenue of $41.95B USD with 4.59% growth. Abbott Laboratories had revenue of $10.97B in the quarter ending December 31, 2024, with 7.16% growth.
Revenue
$41.95B
Revenue Growth
+4.59%
P/S Ratio
n/a
Revenue / Employee
$367.98K
Employees
114,000
Market Cap
178.51B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.95B | 1.84B | 4.59% |
| Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
| Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
| Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
| Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| Shell | 227.10B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| British American Tobacco p.l.c. | 26.18B |
| BP p.l.c. | 144.69B |